190 related articles for article (PubMed ID: 1939648)
41. Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma.
Jenkins RB; Hay ID; Herath JF; Schultz CG; Spurbeck JL; Grant CS; Goellner JR; Dewald GW
Cancer; 1990 Sep; 66(6):1213-20. PubMed ID: 2400971
[TBL] [Abstract][Full Text] [Related]
42. Clear Cell Change in Thyroid Carcinoma: A Clinicopathologic and Molecular Study with Identification of Variable Genetic Anomalies.
Cipriani NA; Agarwal S; Dias-Santagata D; Faquin WC; Sadow PM
Thyroid; 2017 Jun; 27(6):819-824. PubMed ID: 28293986
[TBL] [Abstract][Full Text] [Related]
43. An allelotype of papillary thyroid cancer.
Califano JA; Johns MM; Westra WH; Lango MN; Eisele D; Saji M; Zeiger MA; Udelsman R; Koch WM; Sidransky D
Int J Cancer; 1996 Dec; 69(6):442-4. PubMed ID: 8980243
[TBL] [Abstract][Full Text] [Related]
44. Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma.
Corver WE; Ruano D; Weijers K; den Hartog WC; van Nieuwenhuizen MP; de Miranda N; van Eijk R; Middeldorp A; Jordanova ES; Oosting J; Kapiteijn E; Hovens G; Smit J; van Wezel T; Morreau H
PLoS One; 2012; 7(6):e38287. PubMed ID: 22675538
[TBL] [Abstract][Full Text] [Related]
45. A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci.
Tsilchorozidou T; Vafiadou E; Yovos JG; Romeo G; McKay J; Lesueur F; Bonora E
Thyroid; 2005 Dec; 15(12):1349-54. PubMed ID: 16405407
[TBL] [Abstract][Full Text] [Related]
46. Chromosomal aberrations in thyroid follicular-cell neoplasia: in the search of novel oncogenes and tumour suppressor genes.
Zitzelsberger H; Thomas G; Unger K
Mol Cell Endocrinol; 2010 May; 321(1):57-66. PubMed ID: 19961897
[TBL] [Abstract][Full Text] [Related]
47. Cytogenetic findings in 31 papillary thyroid carcinomas.
Roque L; Clode AL; Gomes P; Rosa-Santos J; Soares J; Castedo S
Genes Chromosomes Cancer; 1995 Jul; 13(3):157-62. PubMed ID: 7669734
[TBL] [Abstract][Full Text] [Related]
48. Clonal origin of non-medullary thyroid tumours assessed by non-random X-chromosome inactivation.
Moniz S; Catarino AL; Marques AR; Cavaco B; Sobrinho L; Leite V
Eur J Endocrinol; 2002 Jan; 146(1):27-33. PubMed ID: 11751063
[TBL] [Abstract][Full Text] [Related]
49. Selected single-nucleotide polymorphisms in FOXE1, SERPINA5, FTO, EVPL, TICAM1 and SCARB1 are associated with papillary and follicular thyroid cancer risk: replication study in a German population.
Sigurdson AJ; Brenner AV; Roach JA; Goudeva L; Müller JA; Nerlich K; Reiners C; Schwab R; Pfeiffer L; Waldenberger M; Braganza M; Xu L; Sturgis EM; Yeager M; Chanock SJ; Pfeiffer RM; Abend M; Port M
Carcinogenesis; 2016 Jul; 37(7):677-684. PubMed ID: 27207655
[TBL] [Abstract][Full Text] [Related]
50. Loss of heterozygosity on chromosome 1p in thyroid adenoma and medullary carcinoma, but not in papillary carcinoma.
Kubo K; Yoshimoto K; Yokogoshi Y; Tsuyuguchi M; Saito S
Jpn J Cancer Res; 1991 Oct; 82(10):1097-103. PubMed ID: 1683348
[TBL] [Abstract][Full Text] [Related]
51. Fluorescence in situ hybridization analysis using PAX8- and PPARG-specific probes reveals the presence of PAX8-PPARG translocation and 3p25 aneusomy in follicular thyroid neoplasms.
Chia WK; Sharifah NA; Reena RM; Zubaidah Z; Clarence-Ko CH; Rohaizak M; Naqiyah I; Srijit D; Hisham AN; Asmiati A; Rafie MK
Cancer Genet Cytogenet; 2010 Jan; 196(1):7-13. PubMed ID: 19963130
[TBL] [Abstract][Full Text] [Related]
52. Allelic loss on chromosomes 2q21 and 19p 13.2 in oxyphilic thyroid tumors.
Stankov K; Pastore A; Toschi L; McKay J; Lesueur F; Kraimps JL; Bonneau D; Gibelin H; Levillain P; Volante M; Papotti M; Romeo G
Int J Cancer; 2004 Sep; 111(3):463-7. PubMed ID: 15221978
[TBL] [Abstract][Full Text] [Related]
53. Deletions of the long arm of chromosome 10 in progression of follicular thyroid tumors.
Zedenius J; Wallin G; Svensson A; Bovèe J; Höög A; Bäckdahl M; Larsson C
Hum Genet; 1996 Mar; 97(3):299-303. PubMed ID: 8786068
[TBL] [Abstract][Full Text] [Related]
54. Allelotyping of follicular thyroid carcinoma: frequent allelic losses in chromosome arms 7q, 11p, and 22q.
Kitamura Y; Shimizu K; Ito K; Tanaka S; Emi M
J Clin Endocrinol Metab; 2001 Sep; 86(9):4268-72. PubMed ID: 11549660
[TBL] [Abstract][Full Text] [Related]
55. Screening of selected genomic areas potentially involved in thyroid neoplasms.
Oriola J; Halperin I; Mallofré C; Muntané J; Angel M; Rivera-Fillat F
Eur J Cancer; 2001 Dec; 37(18):2470-4. PubMed ID: 11720845
[TBL] [Abstract][Full Text] [Related]
56. Cytogenetic analyses of three papillary carcinomas and a follicular adenoma of the thyroid.
Olah E; Balogh E; Bojan F; Juhasz F; Stenszky V; Farid NR
Cancer Genet Cytogenet; 1990 Jan; 44(1):119-29. PubMed ID: 2293877
[TBL] [Abstract][Full Text] [Related]
57. Identification of a 7-cM region of frequent allelic loss on chromosome band 16p13.3 that is specifically associated with anaplastic thyroid carcinoma.
Kadota M; Tamaki Y; Sakita I; Komoike Y; Miyazaki M; Ooka M; Masuda N; Fujiwara Y; Ohnishi T; Tomita N; Sekimoto M; Ohue M; Ikeda T; Kobayashi T; Horii A; Monden M
Oncol Rep; 2000; 7(3):529-33. PubMed ID: 10767363
[TBL] [Abstract][Full Text] [Related]
58. Allelotyping of follicular thyroid tumors.
Zedenius J; Wallin G; Svensson A; Grimelius L; Höög A; Lundell G; Bäckdahl M; Larsson C
Hum Genet; 1995 Jul; 96(1):27-32. PubMed ID: 7607650
[TBL] [Abstract][Full Text] [Related]
59. Cytogenetic abnormalities in a patient with hypercalcemia and papillary thyroid carcinoma.
Pathak S; Hsu TC; Samaan N; Hickey RC
Hum Genet; 1982; 60(3):291-3. PubMed ID: 7106763
[TBL] [Abstract][Full Text] [Related]
60. Deletion of 3p25-->pter in a primary follicular thyroid carcinoma and its metastasis.
Roque L; Castedo S; Clode A; Soares J
Genes Chromosomes Cancer; 1993 Nov; 8(3):199-203. PubMed ID: 7509630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
